Answer
As a precaution, it is preferable to avoid Anzupgo (delgocitinib) cream during pregnancy because pregnancy data are absent or limited (fewer than 300 pregnancy outcomes).
Sources for this answer
- Anzupgo 20 mg/g creamLeo Laboratories Limited · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 2Document updated
Sources checked